Electroporation News and Research

RSS
Study shows efficacy of a heterologous vaccine regimen to induce mucosal protection against COVID-19

Study shows efficacy of a heterologous vaccine regimen to induce mucosal protection against COVID-19

New method for safe engineering of therapeutic cells with photothermal nanofibers

New method for safe engineering of therapeutic cells with photothermal nanofibers

Innovative method greatly simplifies the complexity of delivering vaccines

Innovative method greatly simplifies the complexity of delivering vaccines

Phase 1 open-label trial shows SARS-CoV-2 DNA vaccine induces durable immune response

Phase 1 open-label trial shows SARS-CoV-2 DNA vaccine induces durable immune response

Evaluation of a synthetic DNA SARS-CoV-2 vaccine INO-4800 using a nonhuman primate model

Evaluation of a synthetic DNA SARS-CoV-2 vaccine INO-4800 using a nonhuman primate model

Researchers discover new genetic driver of autism and other developmental disorders

Researchers discover new genetic driver of autism and other developmental disorders

COVID-e-Vax DNA vaccine candidate elicits robust immune responses in preclinical trials

COVID-e-Vax DNA vaccine candidate elicits robust immune responses in preclinical trials

New DNA COVID-19 vaccine proven effective in mice

New DNA COVID-19 vaccine proven effective in mice

Study attempts to standardize humoral immune Correlates of Protection (CoP) in COVID-19

Study attempts to standardize humoral immune Correlates of Protection (CoP) in COVID-19

Researchers take steps to standardize correlates of protection against SARS-CoV-2

Researchers take steps to standardize correlates of protection against SARS-CoV-2

Phase 2 trial shows INO-4800 SARS-CoV-2 DNA vaccine safe and tolerable in adults

Phase 2 trial shows INO-4800 SARS-CoV-2 DNA vaccine safe and tolerable in adults

Phosphatidic acid is a key common substrate for hepatitis C and SARS-CoV-2 replication

Phosphatidic acid is a key common substrate for hepatitis C and SARS-CoV-2 replication

Characterization of lab-produced neutralizing antibodies targeting SARS-CoV-2

Characterization of lab-produced neutralizing antibodies targeting SARS-CoV-2

Scientists launch clinical trial of CRISPR gene correction therapy in patients with sickle cell disease

Scientists launch clinical trial of CRISPR gene correction therapy in patients with sickle cell disease

Advancements in DNA vaccines against COVID-19

Advancements in DNA vaccines against COVID-19

Experimental vaccine protects cynomolgus macaques against Crimean-Congo hemorrhagic fever virus

Experimental vaccine protects cynomolgus macaques against Crimean-Congo hemorrhagic fever virus

Spike-based DNA vaccine shows excellent protection against SARS-CoV-2 in a hamster model

Spike-based DNA vaccine shows excellent protection against SARS-CoV-2 in a hamster model

Researchers identify new strategy to combat loss of skeletal muscle mass

Researchers identify new strategy to combat loss of skeletal muscle mass

New antitumor vaccines control melanoma growth in preclinical models

New antitumor vaccines control melanoma growth in preclinical models

Effective, simple, safe self-amplifying RNA vaccines

Effective, simple, safe self-amplifying RNA vaccines